GSK will use promising results from two studies of its experimental chronic hepatitis B therapy to support planned regulatory ...

Hepatitis B is a virus that can damage the liver and lead to lifelong health problems. The hepatitis B vaccine prevents short ...

The overhaul is the latest in a host of sweeping changes made under the Trump administration by health secretary Robert F ...

Though specific data for bepirovirsen remain under wraps, GSK plans to file for approval in the first quarter of 2026.

The B-Well 1 and B-Well 2 trials evaluated the safety, efficacy, and durability of bepirovirsen in nucleos(t)ide analogue-treated participants with CHB.

GSK's experimental drug to treat chronic hepatitis B infection met the main goal in two closely watched studies, the ...

Kerala has reported its highest-ever number of Hepatitis A cases. As of December 30, 2025, the state recorded 31,536 ...

Kerala records its highest-ever Hepatitis A with 31,536 confirmed and probable cases and 82 deaths as of December 30, 2025..

Kerala is facing a severe hepatitis A outbreak, with over 31,500 cases and 82 deaths reported by late December. The ...

Dr. Reddy’s launches Hevaxin, India’s first approved vaccine for preventing Hepatitis E virus infection in adults aged 18 to ...

Kerala has reported a sharp rise in hepatitis A cases. Here's how the virus spreads, symptoms to watch for, when it turns ...

Hepatitis B is a virus that can damage the liver and lead to lifelong health problems. The hepatitis B vaccine prevents short ...